FDA Grants Approval to First Generic Version of HIV Prevention Drug Lenacapavir
The United States Food and Drug Administration (FDA) has granted tentative approval to the first generic version of Lenacapavir, a long-acting injectable medicine used to prevent HIV infection. The generic version has been developed by India’s Dr. Reddy’s Laboratories. This development is an important step towards making HIV prevention more affordable and accessible, particularly in […]